BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 36438189)

  • 1. Ataxia with oculomotor apraxia type 2 caused by a novel homozygous mutation in SETX gene, and literature review.
    Chen S; Du J; Jiang H; Zhao W; Wang N; Ying A; Li J; Chen S; Shen B; Zhou Y
    Front Mol Neurosci; 2022; 15():1019974. PubMed ID: 36438189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SETX mutations are a frequent genetic cause of juvenile and adult onset cerebellar ataxia with neuropathy and elevated serum alpha-fetoprotein.
    Nanetti L; Cavalieri S; Pensato V; Erbetta A; Pareyson D; Panzeri M; Zorzi G; Antozzi C; Moroni I; Gellera C; Brusco A; Mariotti C
    Orphanet J Rare Dis; 2013 Aug; 8():123. PubMed ID: 23941260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel SETX Mutation in a Taiwanese Patient with Autosomal Recessive Cerebellar Ataxia Detected by Targeted Next-Generation Sequencing, and a Literature Review.
    Chiang PI; Liao TW; Chen CM
    Brain Sci; 2022 Jan; 12(2):. PubMed ID: 35203940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unique Ataxia-Oculomotor Apraxia 2 (AOA2) in Israel with Novel Variants, Atypical Late Presentation, and Possible Identification of a Poison Exon.
    Ponger P; Kurolap A; Lerer I; Dagan J; Chai Gadot C; Mory A; Wilnai Y; Oniashvili N; Giladi N; Gurevich T; Meiner V; Lossos A; Baris Feldman H
    J Mol Neurosci; 2022 Aug; 72(8):1715-1723. PubMed ID: 35676594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ataxia with oculomotor apraxia type 2: clinical, biological and genotype/phenotype correlation study of a cohort of 90 patients.
    Anheim M; Monga B; Fleury M; Charles P; Barbot C; Salih M; Delaunoy JP; Fritsch M; Arning L; Synofzik M; Schöls L; Sequeiros J; Goizet C; Marelli C; Le Ber I; Koht J; Gazulla J; De Bleecker J; Mukhtar M; Drouot N; Ali-Pacha L; Benhassine T; Chbicheb M; M'Zahem A; Hamri A; Chabrol B; Pouget J; Murphy R; Watanabe M; Coutinho P; Tazir M; Durr A; Brice A; Tranchant C; Koenig M
    Brain; 2009 Oct; 132(Pt 10):2688-98. PubMed ID: 19696032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel nonsense mutation in a Japanese family with ataxia with oculomotor apraxia type 2 (AOA2).
    Nakamura K; Yoshida K; Makishita H; Kitamura E; Hashimoto S; Ikeda S
    J Hum Genet; 2009 Dec; 54(12):746-8. PubMed ID: 19893583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and molecular findings of ataxia with oculomotor apraxia type 2 (AOA2) in 5 Tunisian families.
    Hammer MB; El Euch-Fayache G; Nehdi H; Saidi D; Nasri A; Nabli F; Bouhlal Y; Maamouri-Hicheri W; Hentati F; Amouri R
    Diagn Mol Pathol; 2012 Dec; 21(4):241-5. PubMed ID: 23111195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and molecular findings of ataxia with oculomotor apraxia type 2 in 4 families.
    Anheim M; Fleury MC; Franques J; Moreira MC; Delaunoy JP; Stoppa-Lyonnet D; Koenig M; Tranchant C
    Arch Neurol; 2008 Jul; 65(7):958-62. PubMed ID: 18625865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ataxia with oculomotor apraxia type 2: a clinical, pathologic, and genetic study.
    Criscuolo C; Chessa L; Di Giandomenico S; Mancini P; Saccà F; Grieco GS; Piane M; Barbieri F; De Michele G; Banfi S; Pierelli F; Rizzuto N; Santorelli FM; Gallosti L; Filla A; Casali C
    Neurology; 2006 Apr; 66(8):1207-10. PubMed ID: 16636238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterozygous deletion in exon 6 of
    Kinkar JS; Jameel PZ; Kumawat BL; Kalbhor P
    BMJ Case Rep; 2021 Jun; 14(6):. PubMed ID: 34193451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel senataxin mutations in Chinese patients with autosomal recessive cerebellar ataxias by targeted next-generation sequencing.
    Lu C; Zheng YC; Dong Y; Li HF
    BMC Neurol; 2016 Sep; 16(1):179. PubMed ID: 27644330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel SETX variants in a patient with ataxia, neuropathy, and oculomotor apraxia are associated with normal sensitivity to oxidative DNA damaging agents.
    Vantaggiato C; Cantoni O; Guidarelli A; Romaniello R; Citterio A; Arrigoni F; Doneda C; Castelli M; Airoldi G; Bresolin N; Borgatti R; Bassi MT
    Brain Dev; 2014 Sep; 36(8):682-9. PubMed ID: 24183476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and molecular characterization of ataxia with oculomotor apraxia patients in Saudi Arabia.
    Bohlega SA; Shinwari JM; Al Sharif LJ; Khalil DS; Alkhairallah TS; Al Tassan NA
    BMC Med Genet; 2011 Feb; 12():27. PubMed ID: 21324166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Homozygous Variant of SETX Causes Ataxia with Oculomotor Apraxia Type 2.
    Tariq H; Imran R; Naz S
    J Clin Neurol; 2018 Oct; 14(4):498-504. PubMed ID: 30198223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of Spermatogenesis and Infertility in Ataxia with Oculomotor Apraxia Type 2 (AOA2).
    Becherel OJ; Fogel BL; Zeitlin SI; Samaratunga H; Greaney J; Homer H; Lavin MF
    Cerebellum; 2019 Jun; 18(3):448-456. PubMed ID: 30778901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biallelic Mutation of
    Perry MD; Evans MJ; Byrd PJ; Taylor MR
    J Pediatr Genet; 2021 Dec; 10(4):311-314. PubMed ID: 34849277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Pseudodominant inheritance" of ataxia with ocular apraxia type 2 (AOA2).
    Schöls L; Arning L; Schüle R; Epplen JT; Timmann D
    J Neurol; 2008 Apr; 255(4):495-501. PubMed ID: 18350359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of two novel SETX mutations in AOA2 patients reveals aspects of the pathophysiological role of senataxin.
    Airoldi G; Guidarelli A; Cantoni O; Panzeri C; Vantaggiato C; Bonato S; Grazia D'Angelo M; Falcone S; De Palma C; Tonelli A; Crimella C; Bondioni S; Bresolin N; Clementi E; Bassi MT
    Neurogenetics; 2010 Feb; 11(1):91-100. PubMed ID: 19593598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and Genetic Characterization of Brazilian Patients with Ataxia and Oculomotor Apraxia.
    da Costa SCG; Rezende Filho FM; de Freitas JL; de Assis Pereira Matos PCA; Della-Ripa B; França MC; Marques W; Santos M; Cronemberger IVB; Vale TC; Kok F; Alonso I; Pedroso JL; Barsottini OGP
    Mov Disord; 2022 Jun; 37(6):1309-1316. PubMed ID: 35426160
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.